background
mix
bacteri
infect
import
contributor
morbid
mortal
influenza
pandem
evalu
procalcitonin
pct
creactiv
protein
crp
differenti
pneumonia
caus
mix
bacteri
influenza
infect
influenza
infect
alon
method
data
collect
retrospect
period
influenza
pandem
patient
visit
emerg
depart
diagnos
communityacquir
pneumonia
caus
infect
includ
n
result
mix
bacteri
viral
infect
pneumonia
n
significantli
higher
pct
crp
level
pneumonia
caus
influenza
alon
n
p
respect
sensit
specif
detect
mix
bacteri
infect
pneumonia
pct
ng
ml
crp
mg
dl
use
pct
crp
combin
sensit
specif
respect
conclus
procalcitonin
crp
alon
combin
moder
abil
detect
pneumonia
mix
bacteri
infect
pandem
consid
high
specif
combin
low
crp
pct
result
may
suggest
pneumonia
unlik
caus
mix
bacteri
infect
sinc
first
report
influenza
infect
mexico
infect
rapidli
spread
around
world
lead
pandem
accord
may
world
health
organ
report
infect
occur
countri
brought
death
pneumonia
mix
bacteri
infect
aggrav
underli
condit
heart
failur
wellknown
complic
influenza
among
complic
mix
bacteri
infect
especi
known
increas
mortal
morbid
influenza
pandem
influenza
strain
gener
caus
selflimit
ill
crucial
accur
diagnos
concurr
mix
bacteri
infect
ideal
inflammatori
biomark
requir
accur
discriminatori
effect
infecti
noninfecti
diseas
abil
aid
earli
detect
easi
applic
classic
inflammatori
mediat
includ
tumor
necrosi
factor
tnf
interleukin
il
creactiv
protein
crp
recent
develop
marker
procalcitonin
pct
wide
use
diagnosi
infecti
inflammatori
diseas
pct
level
known
higher
bacteri
fungal
parasit
infect
viral
infect
led
pct
use
guid
antibiot
treatment
communityacquir
pneumonia
acut
exacerb
chronic
obstruct
pulmonari
diseas
sever
studi
regard
use
inflammatori
marker
predict
mix
bacteri
infect
pneumonia
exist
retrospect
studi
adult
patient
year
older
visit
emerg
depart
tertiarycar
hospit
seoul
korea
pandem
patient
elig
diagnos
communityacquir
pneumonia
caus
influenza
infect
august
februari
patient
transfer
institut
prior
antibiot
administr
exclud
studi
upon
arriv
ed
laboratori
exam
includ
serum
pct
crp
blood
sputum
cultur
gram
stain
chest
xray
perform
influenza
infect
confirm
realtim
revers
transcriptas
polymeras
chain
reaction
rtpcr
nasopharyng
swab
pneumonia
sever
index
psi
calcul
risk
stratif
serum
pct
measur
vida
brahm
enzymelink
fluoresc
assay
measur
rang
ng
ml
biomerieux
lyon
franc
crp
measur
autom
multichannel
analyz
model
toshiba
saitama
japan
treatment
outcom
classifi
patient
whose
condit
improv
discharg
die
follow
admiss
communityacquir
pneumonia
diagnos
patient
respiratori
symptom
lung
infiltr
chest
xray
rale
auscult
patient
pneumonia
posit
influenza
pcr
diagnos
pneumonia
patient
pneumonia
posit
influenza
pcr
detect
bacteri
pathogen
defin
pneumonia
caus
mix
infect
presenc
bacteri
pathogen
confirm
posit
gram
stain
respiratori
sampl
pathogen
concentr
colonyform
unit
ml
tracheobronchi
aspir
blood
cultur
reveal
bacteri
pathogen
absenc
extrapulmonari
focu
exam
atyp
pathogen
perform
serum
enzym
immunoassay
mycoplasma
antibodi
cold
agglutinin
test
legionella
urin
antigen
test
organ
detect
sputum
consid
pathogen
sputum
qualifi
epitheli
cell
leukocyt
per
low
power
field
data
present
mean
standard
deviat
sd
continu
variabl
absolut
rel
frequenc
categor
variabl
univari
analys
use
conting
tabl
basic
descript
statist
perform
statist
analysi
carri
use
chisquar
test
nomin
data
mannwhitney
test
median
nonparametr
data
student
ttest
parametr
data
demarc
pct
crp
cutoff
valu
distinguish
mix
infect
pneumonia
viral
pneumonia
receiveroper
characterist
roc
curv
analysi
carri
statist
analys
perform
spss
window
spss
inc
chicago
il
usa
report
pvalu
twotail
pvalu
consid
statist
signific
studi
period
total
patient
diagnos
communityacquir
pneumonia
posit
influenza
viru
patient
pneumonia
caus
infect
alon
pneumonia
caus
mix
bacteri
infect
common
bacteri
organ
mix
bacteri
infect
pneumonia
streptococcu
pneumonia
follow
staphylococcu
aureu
pseudomona
aeruginosa
tabl
number
specimen
reveal
caus
organ
blood
cultur
five
sputum
cultur
four
urin
sampl
pneumococc
antigen
mean
age
patient
year
men
ten
patient
die
follow
admiss
mean
valu
initi
pct
concentr
ng
ml
crp
mg
dl
initi
serum
white
blood
cell
wbc
count
mm
baselin
characterist
laboratori
find
clinic
present
pneumonia
pneumonia
initi
laboratori
find
median
rang
radiolog
find
bilater
infiltr
n
pleural
effus
n
psi
median
rang
death
follow
admiss
n
sd
standard
deviat
sbp
systol
blood
pressur
dbp
diastol
blood
pressur
rr
respiratori
rate
pr
puls
rate
bt
bodi
temperatur
spo
oxygen
satur
wbc
white
blood
cell
anc
absolut
neutrophil
count
psi
pneumonia
sever
index
p
versu
differ
statist
signific
roc
curv
analysi
pct
area
curv
confid
interv
ci
pct
cutoff
ng
ml
best
identifi
patient
mix
infect
pneumonia
sensit
specif
posit
predict
valu
neg
predict
valu
figur
crp
area
curv
ci
cutoff
ng
ml
best
identifi
patient
mix
infect
pneumonia
sensit
specif
posit
predict
valu
neg
predict
valu
figur
distribut
pct
crp
pneumonia
infect
alon
pneumonia
caus
mix
infect
also
depict
figur
pct
crp
concentr
consid
togeth
accuraci
diagnost
criteria
detect
mix
infect
pneumonia
follow
sensit
specif
posit
predict
valu
neg
predict
valu
tabl
studi
show
serum
pct
concentr
significantli
higher
patient
mix
infect
pneumonia
compar
infect
alon
indic
marker
could
use
discrimin
condit
although
statist
less
power
crp
could
also
aid
discrimin
mix
bacteri
infect
viral
pneumonia
criteria
consid
togeth
owe
high
specif
high
neg
predict
valu
may
improv
accuraci
discrimin
pneumonia
caus
mix
infect
pneumonia
caus
influenza
infect
alon
mix
bacteri
infect
import
contributor
morbid
mortal
influenza
pandem
also
period
season
influenza
explain
increas
pathogen
virul
bacteri
organ
coinfect
set
therefor
crucial
differenti
mix
bacteri
infect
influenza
viral
infect
studi
cutoff
valu
best
differenti
mix
bacteri
infect
pneumonia
viral
pneumonia
ng
ml
pct
mg
dl
crp
cutoff
valu
pct
discrimin
bacteri
infect
viral
infect
vari
among
previou
studi
ng
ml
studi
chirouz
et
al
ng
ml
studi
sever
acut
respiratori
syndrom
chua
et
al
ng
ml
studi
ingram
et
al
varieti
present
cutoff
valu
may
attribut
presenc
larg
overlap
pct
concentr
viral
bacteri
infect
util
pct
crp
biomark
discuss
variou
studi
role
pct
crp
discrimin
bacteri
mix
infect
pneumonia
report
recent
studi
patient
guervilli
et
al
result
show
pct
valu
statist
higher
patient
mix
bacteri
infect
measur
pct
valu
hour
admiss
cutoff
ng
ml
pct
sensit
specif
neg
predict
valu
posit
predict
valu
respect
studi
comparison
examin
pct
crp
valu
initi
ed
visit
data
show
pct
crp
use
discrimin
viral
infect
mix
bacteri
infect
cutoff
ng
ml
pct
mg
dl
crp
distinct
cutoff
perform
marker
may
attribut
differ
time
measur
inflammatori
marker
total
patient
number
two
studi
studi
includ
patient
pct
crp
measur
arriv
ed
mix
bacteri
infect
import
contributor
poor
outcom
influenza
pertin
antibiot
administr
crucial
howev
indiscrimin
antibiot
usag
may
lead
bacteri
resist
complic
drug
therefor
decis
stop
empir
antibiot
cours
influenza
undoubtedli
possess
problem
wright
et
al
describ
diffus
infiltr
chest
xray
leukopenia
favor
infect
caus
influenza
alon
lobar
infiltr
leukocytosi
favor
mix
bacteri
infect
howev
discrimin
mix
bacteri
infect
influenza
infect
method
would
possibl
case
pandem
studi
signific
differ
radiograph
find
found
furthermor
wbc
absolut
neutrophil
count
lymphocyt
count
significantli
differ
two
group
therefor
clinician
reli
radiograph
find
blood
cell
count
inflammatori
marker
includ
serum
pct
crp
concentr
requir
aid
diagnosi
discrimin
differ
type
pneumonia
accord
manag
protocol
influenza
institut
patient
initi
administ
oseltamivir
prophylact
antibiot
set
combin
low
pct
low
crp
may
use
reduc
durat
antibiot
administr
studi
sever
limit
sampl
size
small
natur
retrospect
studi
innat
limit
recent
studi
shown
serum
pct
concentr
use
make
decis
concern
antibiot
administr
durat
trend
pct
valu
time
may
import
initi
pct
level
howev
studi
evalu
initi
pct
valu
ed
visit
pct
determin
cover
medic
insur
korea
therefor
cost
prohibit
factor
routin
use
biomark
followup
also
acknowledg
limit
mix
infect
group
microbiolog
confirm
bacteri
diagnosi
made
may
creat
bia
fact
caus
bacteri
organ
confirm
sole
respiratori
sampl
blood
cultur
immunoassay
lack
demonstr
bacteri
etiolog
could
rule
role
studi
demonstr
biolog
marker
pct
crp
alon
combin
moder
abil
detect
pneumonia
caus
mix
bacteri
infect
pandem
high
specif
use
pct
crp
combin
may
abl
discrimin
pneumonia
caus
mix
infect
pneumonia
caus
viral
infect
may
aid
clinician
accur
identifi
patient
administr
empir
antibiot
could
stop
prospect
studi
valid
result
requir
